SVV-001

AXP000122.1 · Oncolytic virus

Platform
Seneca Valley virus (wild-type isolate)
Originator
Neotropix
Sponsor
Neotropix

Names

NameTypeSource
SVV-001preferred name, codecurator, ncit
NTX-010codencit
Seneca Valley Virus-001synonymncit

Virus

Role
Oncolytic
Family
Picornaviridae
Virus
Senecavirus A (NCBI Taxonomy 390157)
Strain
SVV-001 (wild-type isolate)
Replication
replicating
Modifications
none (wild-type isolate)
Route
intravenous
Source
evidence

Cross-references

NCI Thesaurus
C62524

Approvals

No regulatory approval recorded.

Clinical trials (4)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT06889493SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)RecruitingPhase 12025-05-192030-06-0136Neuroendocrine Carcinoma; Neuroendocrine Tumors
NCT01017601Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTerminatedPhase 22010-012013-0159Lung Cancer
NCT01048892Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesCompletedPhase 12009-092013-0622Adrenocortical Carcinoma; Gastrointestinal Carcinoid Tumor; Kidney Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
NCT00314925Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesUnknownPhase 12006-042008-1260Carcinoid; Neuroendocrine

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 31605793A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2020cited by trial NCT01017601
PMID 25307519Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.Pediatric blood & cancer2015name in title: NTX-010
PMID 21304001Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.Clinical cancer research : an official journal of the American Association for Cancer Research2011name in title: SVV-001
PMID 18391430Crystallization and preliminary X-ray diffraction studies of Seneca Valley virus-001, a new member of the Picornaviridae family.Acta crystallographica. Section F, Structural biology and crystallization communications2008cited by trial NCT00314925

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 37415222Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.Journal of translational medicine2023name in title: SVV-001
PMID 37749907Oncolytic virotherapies for pediatric tumors.Expert opinion on biological therapy2023name in abstract: SVV-001
PMID 36084546Characterisation of a Seneca Valley virus thermostable mutant.Virology2022name in abstract: SVV-001
PMID 36090051Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.Frontiers in molecular biosciences2022name in abstract: SVV-001
PMID 36467495Progress of oncolytic virotherapy for neuroblastoma.Frontiers in pediatrics2022name in abstract: NTX-010
PMID 34332591Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis.Virology journal2021name in abstract: NTX-010
PMID 30029014Pathogenicity and cross-reactive immune responses of a historical and a contemporary Senecavirus A strains in pigs.Virology2018name in abstract: SVV-001
PMID 27371541Senecavirus A.Veterinary pathology2017name in abstract: Seneca Valley Virus-001
PMID 28475630Genome wide analysis of the evolution of Senecavirus A from swine clinical material and assembly yard environmental samples.PloS one2017name in abstract: SVV-001
PMID 27660749Oncolytic Seneca Valley Virus: past perspectives and future directions.Oncolytic virotherapy2016name in abstract: SVV-001
PMID 26069962Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy.PloS one2015name in abstract: SVV-001
PMID 23658322Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.Neuro-oncology2013name in title: SVV-001
PMID 23739064Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.Journal of the National Cancer Institute2013name in abstract: SVV-001
PMID 22971818Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.The Journal of general virology2012name in title: SVV-001
PMID 21075780A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.Neuro-oncology2011name in title: SVV-001
PMID 20582972Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program.Pediatric blood & cancer2010name in title: NTX-010
PMID 18420805Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus.The Journal of general virology2008name in title: Seneca Valley Virus-001
PMID 18940610Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus.Structure (London, England : 1993)2008name in title: Seneca Valley Virus-001
PMID 17971529Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.Journal of the National Cancer Institute2007name in abstract: Seneca Valley Virus-001
PMID 18006805Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus.Cancer research2007name in abstract: SVV-001

NIH grants

ProjectTitleOrganisationPIYearsLinked by
M01RR000188ADVL0911 A PHASE 1 DOSE ESCALATION STUDY OF SENECABAYLOR COLLEGE OF MEDICINETHOMPSON, PATRICK2011–2011name in abstract: SVV-001

Notes

Naturally occurring picornavirus with tropism for neuroendocrine tumours; development code NTX-010. Trials in small cell lung cancer and in paediatric neuroendocrine tumours. Discontinued; Neotropix no longer active.

How to cite

SVV-001 (AXP000122.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000122.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.